Malmö, Sweden

Henrik Von Wachenfeldt

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henrik Von Wachenfeldt. Retrieved from https://idiyas.com/inventor/henrik-von-wachenfeldt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Henrik Von Wachenfeldt

Introduction

Henrik Von Wachenfeldt is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating diseases. With a total of 3 patents to his name, his work reflects a commitment to advancing medical science.

Latest Patents

Henrik's latest patents include innovative compounds and salts that are useful for treating various diseases. The first patent discloses compounds according to Formula (I), which are designed to address specific medical conditions. The second patent expands on this by detailing compounds according to Formulae (I), (II), and (VIII), further enhancing the potential for treatment options.

Career Highlights

Henrik is currently associated with Acadia Pharmaceuticals Inc., a company known for its focus on innovative therapies for central nervous system disorders. His role at Acadia has allowed him to collaborate with other talented professionals in the field, contributing to the development of groundbreaking treatments.

Collaborations

Some of Henrik's notable coworkers include Ethan S. Burstein and Roger Olsson. Their combined expertise fosters a collaborative environment that enhances the research and development process.

Conclusion

Henrik Von Wachenfeldt's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare through scientific advancements. His work continues to pave the way for new treatment options that can benefit many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…